Related Experiment Videos
Coronary artery disease and the MEF2A transcription factor
1Department of Molecular Biology, University of Texas, Southwestern Medical Center, Dallas, TX 75390, USA. eric.olson@utsouthwestern.edu
Insights
A mutation in the MEF2A gene predisposes families to coronary artery disease (CAD) and myocardial infarction (MI). This discovery highlights MEF2A's role in cardiovascular development and CAD mechanisms.
Area of Science:
- Cardiovascular biology
- Molecular genetics
Background:
- Coronary artery disease (CAD) arises from vascular wall lesions, leading to myocardial infarction (MI) and stroke.
- Genetic factors play a significant role in the predisposition to CAD and MI.
Purpose of the Study:
- To investigate the genetic basis of a familial predisposition to CAD and MI.
- To identify the specific gene mutation responsible for increased CAD risk in a human pedigree.
Main Methods:
- Human pedigree analysis was employed to track the inheritance of CAD and MI.
- Genetic sequencing was performed to identify mutations within the pedigree.
Main Results:
- A specific mutation was identified in the MEF2A transcription factor gene in individuals with CAD and MI.
- This mutation was found to segregate with the disease phenotype within the studied family.
Conclusions:
- The MEF2A transcription factor plays a crucial role in cardiovascular development.
- Mutations in MEF2A represent a novel genetic cause of coronary artery disease and myocardial infarction.
- Further research is warranted to elucidate the precise mechanisms by which MEF2A mutations contribute to CAD.
Abstract:
Coronary artery disease (CAD) that results from lesions of the vascular wall is a major cause of myocardial infarction (MI) and stroke. A human pedigree with a predisposition to CAD and MI has been shown to harbor a mutation in the MEF2A transcription factor. These findings reveal a new function for this regulator of cardiovascular development and raise intriguing questions about the underlying mechanisms of CAD.